Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

IRWDIRWD
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in IRONWOOD PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 3.3M shares of IRWD (IRONWOOD PHARMACEUTICALS INC), worth $14M as of 2026-Q2. The position was increased (+23.2% shares). IRWD represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$14M

Current Shares

3.3M

Total Value Change

+$8.9M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+23.2%
$14M0.0%$4.21
34
2026-Q1
Increased
2.7M
+111.0%
$9.4M0.0%$3.51
45
2025-Q4
Increased
1.3M
+17.6%
$4.3M0.0%$3.37
31
2025-Q3
Decreased
1.1M
-24.9%
$1.4M0.0%$1.31
0
2025-Q2
Decreased
1.4M
-8.3%
$1M0.0%$0.72
0
2025-Q1
Increased
1.6M
+72.1%
$2.3M0.0%$1.47
39
2024-Q4
Decreased
915,272
-25.2%
$4.1M0.0%$4.43
0
2024-Q3
Decreased
1.2M
-21.8%
$5M0.0%$4.12
0

Other major holders of IRWD: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used